What is DAWN stock price today?

Visit our real-time dashboard for the current DAWN stock price and live market data.

Is DAWN stock going up or down today?

DAWN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy DAWN stock now?

The decision to buy DAWN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is DAWN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for DAWN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is DAWN stock overvalued or undervalued?

Use our DCF valuation calculator to determine if DAWN is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is DAWN's P/E ratio?

P/E ratio data for DAWN will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is DAWN's market cap?

DAWN (Day One Biopharmaceuticals Inc) has a market capitalization of $0.66 billion, making it a small-cap stock.

What is DAWN's price to book ratio?

Price-to-book ratio for DAWN is available on our dashboard along with other valuation metrics.

Does DAWN pay dividends?

DAWN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is DAWN's dividend yield?

DAWN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is DAWN stock a good long-term investment?

DAWN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is DAWN's revenue growth rate?

Revenue growth data for DAWN is available on our dashboard with detailed financial statement analysis.

Profitability metrics for DAWN are available on our dashboard with complete income statement analysis.

What are the risks of investing in DAWN?

Key risks for DAWN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does DAWN compare to its competitors?

Compare DAWN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize DAWN's performance and positioning.

What is DAWN's stock price target for 2026?

Visit our prediction page for AI-powered price targets for DAWN with bull, base, and bear case scenarios.

What do analysts say about DAWN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for DAWN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is DAWN's next earnings report?

DAWN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

DAWN - Day One Biopharmaceuticals Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc (DAWN) common stock

Price Chart

Loading chart...

DAWN Key Statistics

Market Cap

$656.83M

How DAWN Compares to Peers

DAWN is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 4

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
DAWN(This stock)	$656.83M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 13, 2026 at 4:27 AM EDT

Ready to invest in DAWN?

Commission-free trading available. Affiliate links.

DAWN Lician Score

10% confidence

6.0/10

Good

DAWN has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates DAWNacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

DAWN Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for DAWN

Dashboard

Enter a ticker to analyze